Financial results for the period ended September 30, 2026
As filed · Blue Jet Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
EarningsNotablemateriality 70 out of 100
What happened
FactFinancial results for the period ended September 30, 2026. Limited Review Report thereon is enclosed herewith.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
RevisedEarlierQ1 FY27
Our reported gross margin at 53% is a reduction of 3% over previous quarter.
NowQ1 FY27
Reported operating EBITDA is 33.5% compared to 30.4% in the previous quarter, an increase of 3%.
Change
FactTarget revision
Implication
CapitSignal interpretationThe stated figure moved -36.79%.confidence 60%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- Moving on to capex. Our expected capital expenditure for the next three years will be INR1,000-odd crores, and (management committed by FY27)
- Given the order visibility in this particular molecule, we believe this performance can be sustained for FY27. (management committed by FY27)
Evidence
- Blue Jet Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%